These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 2777

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis of [1-sarcosine, 8-O-methylserine]angiotensin II and 1-substituted analogues of [8-threonine]angiotensin II as antagonists of angiotensin II.
    Khosla MC, Hall MM, Munoz-Ramírez H, Khairallah PA, Bumpus FM.
    J Med Chem; 1977 Feb; 20(2):253-6. PubMed ID: 836496
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis of angiotensin II antagonists containing sarcosine in position 7.
    Moore GJ, Oudeman EM, Ko D, Nystrom DM.
    J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin antagonists and the adrenal cortex and medulla.
    Peach MJ, Ackerly JA.
    Fed Proc; 1976 Nov; 35(13):2502-7. PubMed ID: 976492
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo studies of (1-sarcosine, 8-threonine) angiotensin II.
    Muñoz-Ramírez H, Khosla MC, Hall MM, Bumpus FM, Khairallah PA.
    Res Commun Chem Pathol Pharmacol; 1976 Apr; 13(4):649-63. PubMed ID: 4864
    [Abstract] [Full Text] [Related]

  • 7. A new approach to angiotensin antagonists: methylation of the tyrosine hydroxyl in angiotensin II.
    Scanlon MN, Matsoukas JM, Franklin KJ, Moore GJ.
    Life Sci; 1984 Jan 23; 34(4):317-21. PubMed ID: 6546405
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Structure-activity relationships for the competitive angiotensin antagonist [sarcosine,O-methyltyrosine4]angiotensin II (sarmesin).
    Goghari MH, Franklin KJ, Moore GJ.
    J Med Chem; 1986 Jun 23; 29(6):1121-4. PubMed ID: 3754902
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and evaluation of (Des-Asp1)angiotensin I as a precursor for (Des-Asp1)angiotensin II ("Angiotensin III").
    Tsai BS, Peach MJ, Khosla MC, Bumpus FM.
    J Med Chem; 1975 Dec 23; 18(12):1180-3. PubMed ID: 172631
    [Abstract] [Full Text] [Related]

  • 11. Antagonists of angiotensin II containing N-methyl-L-alanine and DL-nipecotic acid in position 7.
    Moore GJ, Ko EM.
    Can J Physiol Pharmacol; 1979 Jul 23; 57(7):763-6. PubMed ID: 487287
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists.
    Bovy PR, O'Neal JM, Olins GM, Patton DR, McMahon EG, Palomo M, Koepke JP, Salles KS, Trapani AJ, Smits GJ.
    J Med Chem; 1990 May 23; 33(5):1477-82. PubMed ID: 2329570
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of analogs of (8-isoleucine)angiotensin II with variations in position 1.
    Khosla MC, Hall MM, Smeby RR, Bumpus FM.
    J Med Chem; 1974 Apr 23; 17(4):431-3. PubMed ID: 4364509
    [No Abstract] [Full Text] [Related]

  • 15. Amino acid side chain conformation in angiotensin II and analogs: correlated results of circular dichroism and 1H nuclear magnetic resonance.
    Piriou F, Lintner K, Fermandjian S, Fromageot P, Khosla MC, Smeby RR, Bumpus FM.
    Proc Natl Acad Sci U S A; 1980 Jan 23; 77(1):82-6. PubMed ID: 6928653
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of two structurally related analogs of Asp1-Ile5-angiotensin II.
    Türker RK, Gündoğan NU.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Jan 23; 282(4):411-20. PubMed ID: 4367918
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of three angiotensin II antagonists, [Sar1, Thr8]-, [Sar1, Ile8]- and [Sar1, Ala8]angiotensin II on blood pressure and endocrine factors in normal subjects.
    Hata T, Ogihara T, Nakamaru M, Gotoh S, Masuo K, Saeki S, Kumagai A, Kumahara Y.
    Eur J Clin Pharmacol; 1982 Jan 23; 23(1):7-10. PubMed ID: 6751836
    [Abstract] [Full Text] [Related]

  • 20. Importance of the N-terminal domain of the type II angiotensin antagonist sarmesin for receptor blockade.
    Matsoukas J, Cordopatis P, Belte U, Goghari MH, Ganter RC, Franklin KJ, Moore GJ.
    J Med Chem; 1988 Jul 23; 31(7):1418-21. PubMed ID: 2455051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.